slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 37,411-37,440
Pages 2,019
Rows per page 30
Component
37,411-37,440 of 60,568
22
Uses a structured table format to map strategic initiatives to outcomes.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations Beat · Solution1 hit
06
The slide uses a Gantt-style visualization to represent clinical trial progress for multiple drug candidates.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
12
Includes clinical trial data visualization and product summary table.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
18
The slide uses a matrix-style comparison table to highlight competitive advantages.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
22
Includes a quote from Keith Nuechterlein and a detailed clinical trial timeline.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
25
The slide uses a checkmark system to highlight specific advantages of RL-007 and a few competitors.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
28
Includes a sidebar summary and a clinical trial design overview.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a checkmark matrix to highlight the competitive advantage of the company's drug candidate.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
32
Includes a summary table on the left and clinical trial data/roadmap on the right.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
33
The table highlights DMX-1002's unique profile compared to withdrawal support and maintenance therapies.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style visualization to represent clinical trial progress for various drug candidates.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · AgitationLoop · Cost Of Inaction1 hit
36
Includes study design diagram and assessment schedule table.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
06
The slide uses a process-flow style table to outline the clinical trial structure.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
03
Avenue Therapeutics | IPO Presentation Deck | 30 slidesAvenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
05
The slide uses a simple additive equation visual to represent the growth of the company's CNS portfolio.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
06
The slide uses a Gantt-style visualization to track drug development progress.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
10
The table uses checkmarks to indicate the strength of effect for different GABA-A subtypes (alpha 1, 2, 3, 5).Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Solution1 hit
20
The slide uses a comparison table to frame BAER-101's selectivity profile as a competitive advantage.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 1 hit
15
Includes detailed footnotes regarding non-GAAP measures and definitions.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
16
Includes a footnote regarding non-GAAP financial measures.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
17
Includes footnotes regarding non-GAAP measures and presentation revisions.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
18
Includes footnotes detailing non-GAAP measures and business realignments.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
19
Includes footnotes explaining the composition of 'All Other' and specific tax credit adjustments.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview1 hit
31
The slide uses a table to demonstrate long-term strategic shifts in loan portfolio composition and capital adequacy.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · Appendix Data1 hit
32
Contains detailed accounting definitions and segment-level financial data.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · Appendix Data1 hit
10
The slide uses a comparison framework to highlight efficiency gains in drug discovery.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
17
The table presents financial data in thousands of pounds (£'000) for the six months ended June 30th.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · Financials1 hit
28
The slide explains the impact of one-off business combination costs on the reported operating loss for the six months ended 30 June 2022.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
29
The slide provides specific context for non-cash adjustments and working capital movements.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
46
The slide uses a comparison table to contrast the drug's mechanism of action against competitors and highlights safety concerns with current standards of care.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit